![Mark A. Gohr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark A. Gohr
Director of Finance/CFO at ANTH1, Inc.
Profile
Mark A.
Gohr is currently the Chief Financial & Accounting Officer at ANTH1, Inc. He completed his undergraduate degree at Hastings College and his graduate degree at The University of Colorado.
Mark A. Gohr active positions
Companies | Position | Start |
---|---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Director of Finance/CFO | 2010-06-16 |
Training of Mark A. Gohr
The University of Colorado | Graduate Degree |
Hastings College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
- Stock Market
- Insiders
- Mark A. Gohr